Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study.
Cancer
; 126(24): 5239-5246, 2020 12 15.
Article
in En
| MEDLINE
| ID: mdl-32931029
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Chemoradiotherapy
/
Trastuzumab
/
Antineoplastic Agents, Immunological
/
Mastectomy
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Cancer
Year:
2020
Type:
Article